MedPath

Searching for non-invasive Magnetic Resonance-based markers for CrAT activity and carnitine availability

Completed
Conditions
Phosphocreatine kinetic and exercise metabolism
10013317
Registration Number
NL-OMON48547
Lead Sponsor
niversiteit Maastricht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
13
Inclusion Criteria

- Males
- Generally healthy (not cardiovascular complications)
- Age 18-40 years old
- BMI 18 - 28 kg/m2
- No medication use that interfere with the aims of the study
- Stable level of daily physical activity or training for at least 6 months

Exclusion Criteria

- Regular smokers, drug abuse
- Participation in other studies
- Weight gain/loss > 3 kg in the last 6 months
- Contraindications for MRS scans
- Vegetarian eating behavior
- Females

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>- Skeletal muscle phosphocreatine on-kinetic (pmol / kg tissue) at the<br /><br>beggining of exercise measured by MRS technique<br /><br><br /><br>- Protein content and activity of carnitine acetyltransferase (CrAT) determined<br /><br>in muscle biopsy</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>- Acetylcarnitine levels in skeletal muscle measured by MRS technique (mmol/kg<br /><br>wet weight) at resting and post exercise condition<br /><br><br /><br>- Muscle tissue oxygenation measured by Blood Oxygen level-dependent (BOLD) MRI<br /><br>technique.<br /><br><br /><br>- Ex vivo skeletal muscle mitochondrial function expressed as O2 consumption in<br /><br>pmol/mg/min, determined from muscle biopsy sample<br /><br><br /><br>- Total carnitine availability and protein content, expression/activity of<br /><br>regulatory enzyme involved in the skeletal muscle acetylcarnitine formation<br /><br>(determined in muscle biopsies)<br /><br><br /><br></p><br>
© Copyright 2025. All Rights Reserved by MedPath